HighTower Advisors’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.93M Sell
8,818
-1,369
-13% -$300K ﹤0.01% 1586
2025
Q1
$2.28M Sell
10,187
-163
-2% -$36.5K ﹤0.01% 1454
2024
Q4
$3.39M Buy
10,350
+1,812
+21% +$594K ﹤0.01% 1227
2024
Q3
$2.58M Sell
8,538
-963
-10% -$291K ﹤0.01% 1361
2024
Q2
$3.13M Buy
9,501
+282
+3% +$92.9K ﹤0.01% 1214
2024
Q1
$3.65M Sell
9,219
-145
-2% -$57.5K 0.01% 1109
2023
Q4
$3.29M Sell
9,364
-1,774
-16% -$622K 0.01% 1166
2023
Q3
$4.21M Sell
11,138
-436
-4% -$165K 0.01% 1002
2023
Q2
$4.45M Buy
11,574
+59
+0.5% +$22.7K 0.01% 962
2023
Q1
$3.98M Buy
11,515
+972
+9% +$336K 0.01% 954
2022
Q4
$2.48M Buy
10,543
+1,057
+11% +$248K 0.01% 1170
2022
Q3
$2.31M Sell
9,486
-48
-0.5% -$11.7K 0.01% 1153
2022
Q2
$2.89M Sell
9,534
-1,218
-11% -$369K 0.01% 1056
2022
Q1
$4.42M Sell
10,752
-4,525
-30% -$1.86M 0.01% 953
2021
Q4
$7.17M Buy
15,277
+5,453
+56% +$2.56M 0.02% 732
2021
Q3
$4.17M Buy
9,824
+1,589
+19% +$675K 0.01% 908
2021
Q2
$2.96M Buy
8,235
+966
+13% +$347K 0.01% 1022
2021
Q1
$2.05M Buy
+7,269
New +$2.05M 0.01% 1117
2020
Q4
Sell
-7,309
Closed -$2M 2648
2020
Q3
$2M Buy
7,309
+2,541
+53% +$695K 0.01% 867
2020
Q2
$1.07M Buy
4,768
+454
+11% +$102K 0.01% 1077
2020
Q1
$658K Buy
4,314
+210
+5% +$32K ﹤0.01% 1192
2019
Q4
$622K Sell
4,104
-1,054
-20% -$160K ﹤0.01% 1352
2019
Q3
$729K Buy
5,158
+53
+1% +$7.49K ﹤0.01% 1337
2019
Q2
$642K Buy
5,105
+372
+8% +$46.8K ﹤0.01% 1395
2019
Q1
$515K Buy
4,733
+444
+10% +$48.3K ﹤0.01% 1446
2018
Q4
$423K Buy
4,289
+1,489
+53% +$147K ﹤0.01% 1438
2018
Q3
$343K Buy
+2,800
New +$343K ﹤0.01% 1660